Literature DB >> 17115192

Treatment of steroid-resistant membranous lupus nephritis with plasmapheresis and low-dose cyclosporine.

Shuichiro Fujinaga, Yoshiyuki Ohtomo, Daisuke Umino, Hiroshi Mochizuki, Mayako Takemoto, Toshiaki Shimizu, Yuichiro Yamashiro, Kazunari Kaneko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17115192     DOI： 10.1007/s00467-006-0356-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  6 in total

Review 1.  Membranous lupus nephritis.

Authors:  H A Austin; G G Illei
Journal:  Lupus       Date:  2005       Impact factor: 2.911

Review 2.  Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature.

Authors:  D Hallegua; D J Wallace; A L Metzger; R Z Rinaldi; J R Klinenberg
Journal:  Lupus       Date:  2000       Impact factor: 2.911

Review 3.  Cellular mechanisms of lipid injury in the glomerulus.

Authors:  D Schlondorff
Journal:  Am J Kidney Dis       Date:  1993-07       Impact factor: 8.860

4.  The nephrotic syndrome, lipids, and risk factors for cardiovascular disease.

Authors:  J Radhakrishnan; A S Appel; A Valeri; G B Appel
Journal:  Am J Kidney Dis       Date:  1993-07       Impact factor: 8.860

5.  Cyclosporine treatment of lupus membranous nephropathy.

Authors:  J Radhakrishnan; C L Kunis; V D'Agati; G B Appel
Journal:  Clin Nephrol       Date:  1994-09       Impact factor: 0.975

6.  Severe hypercholesterolemia inhibits cyclosporin A efficacy in a dose-dependent manner in children with nephrotic syndrome.

Authors:  E Ingulli; A Tejani
Journal:  J Am Soc Nephrol       Date:  1992-08       Impact factor: 10.121
  6 in total
  1 in total

1.  Immunoadsorption: a new strategy to induce remission in membranous lupus nephritis.

Authors:  Tim Ulinski; Aurélie Davourie-Salandre; Isabelle Brocheriou; Bilal Aoun
Journal:  Case Rep Nephrol Urol       Date:  2014-03-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.